tetano
Editor, Senior Moderator
NPJ Vaccines
. 2022 Jan 27;7(1):11.
doi: 10.1038/s41541-022-00435-7.
Pre-existing antibodies directed against a tetramerizing domain enhance the immune response against artificially stabilized soluble tetrameric influenza neuraminidase
João Paulo Portela Catani[SUP] 1 2 [/SUP], Emma R Job[SUP] 1 2 3 [/SUP], Tine Ysenbaert[SUP] 1 2 [/SUP], Anouk Smet[SUP] 1 2 [/SUP], Satyajit Ray[SUP] 4 [/SUP], Lauren LaRue[SUP] 4 [/SUP], Svetlana Stegalkina[SUP] 4 [/SUP], Mario Barro[SUP] 4 [/SUP], Thorsten U Vogel[SUP] 5 [/SUP], Xavier Saelens[SUP] 6 7 [/SUP]
Affiliations
Abstract
The neuraminidase (NA) is an abundant antigen at the surface of influenza virions. Recent studies have highlighted the immune-protective potential of NA against influenza and defined anti-NA antibodies as an independent correlate of protection. Even though NA head domain changes at a slightly slower pace than hemagglutinin (HA), NA is still subject to antigenic drift, and therefore an NA-based influenza vaccine antigen may have to be updated regularly and thus repeatedly administered. NA is a tetrameric type II membrane protein, which readily dissociates into dimers and monomers when expressed in a soluble form. By using a tetramerizing zipper, such as the tetrabrachion (TB) from Staphylothermus marinus, it is possible to stabilize soluble NA in its active tetrameric conformation, an imperative for the optimal induction of protective NA inhibitory antibodies. The impact of repetitive immunizations with TB-stabilized antigens on the immunogenicity of soluble TB-stabilized NA is unknown. We demonstrate that TB is immunogenic in mice. Interestingly, preexisting anti-TB antibodies enhance the anti-NA antibody response induced by immunization with TB-stabilized NA. This immune-enhancing effect was transferable by serum and operated independently of activating Fcγ receptors. We also demonstrate that priming with TB-stabilized NA antigens, enhances the NA inhibitory antibody responses against a heterosubtypic TB-stabilized NA. These findings have implications for the clinical development of oligomeric vaccine antigens that are stabilized by a heterologous oligomerizing domain.
. 2022 Jan 27;7(1):11.
doi: 10.1038/s41541-022-00435-7.
Pre-existing antibodies directed against a tetramerizing domain enhance the immune response against artificially stabilized soluble tetrameric influenza neuraminidase
João Paulo Portela Catani[SUP] 1 2 [/SUP], Emma R Job[SUP] 1 2 3 [/SUP], Tine Ysenbaert[SUP] 1 2 [/SUP], Anouk Smet[SUP] 1 2 [/SUP], Satyajit Ray[SUP] 4 [/SUP], Lauren LaRue[SUP] 4 [/SUP], Svetlana Stegalkina[SUP] 4 [/SUP], Mario Barro[SUP] 4 [/SUP], Thorsten U Vogel[SUP] 5 [/SUP], Xavier Saelens[SUP] 6 7 [/SUP]
Affiliations
- PMID: 35087067
- DOI: 10.1038/s41541-022-00435-7
Abstract
The neuraminidase (NA) is an abundant antigen at the surface of influenza virions. Recent studies have highlighted the immune-protective potential of NA against influenza and defined anti-NA antibodies as an independent correlate of protection. Even though NA head domain changes at a slightly slower pace than hemagglutinin (HA), NA is still subject to antigenic drift, and therefore an NA-based influenza vaccine antigen may have to be updated regularly and thus repeatedly administered. NA is a tetrameric type II membrane protein, which readily dissociates into dimers and monomers when expressed in a soluble form. By using a tetramerizing zipper, such as the tetrabrachion (TB) from Staphylothermus marinus, it is possible to stabilize soluble NA in its active tetrameric conformation, an imperative for the optimal induction of protective NA inhibitory antibodies. The impact of repetitive immunizations with TB-stabilized antigens on the immunogenicity of soluble TB-stabilized NA is unknown. We demonstrate that TB is immunogenic in mice. Interestingly, preexisting anti-TB antibodies enhance the anti-NA antibody response induced by immunization with TB-stabilized NA. This immune-enhancing effect was transferable by serum and operated independently of activating Fcγ receptors. We also demonstrate that priming with TB-stabilized NA antigens, enhances the NA inhibitory antibody responses against a heterosubtypic TB-stabilized NA. These findings have implications for the clinical development of oligomeric vaccine antigens that are stabilized by a heterologous oligomerizing domain.